MDT

88.49

+0.49%↑

A

115.97

-0.64%↓

VEEV

157.32

-7.12%↓

HQY

83.84

+2.66%↑

TLRY

6.83

+1.49%↑

MDT

88.49

+0.49%↑

A

115.97

-0.64%↓

VEEV

157.32

-7.12%↓

HQY

83.84

+2.66%↑

TLRY

6.83

+1.49%↑

MDT

88.49

+0.49%↑

A

115.97

-0.64%↓

VEEV

157.32

-7.12%↓

HQY

83.84

+2.66%↑

TLRY

6.83

+1.49%↑

MDT

88.49

+0.49%↑

A

115.97

-0.64%↓

VEEV

157.32

-7.12%↓

HQY

83.84

+2.66%↑

TLRY

6.83

+1.49%↑

MDT

88.49

+0.49%↑

A

115.97

-0.64%↓

VEEV

157.32

-7.12%↓

HQY

83.84

+2.66%↑

TLRY

6.83

+1.49%↑

Kodu・Aktsiate loetelu・Lyell Immunopharma Inc

Search

Lyell Immunopharma Inc

Avatud

23.69 3.54

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

21.01

Max

23.92

Põhinäitajad
By Trading Economics
Sissetulek	-102M -141M
Müük	-9K 6K
Aktsiakasum	-7.68
Kasumimarginaal	-2,345,383.333
Töötajad	300
EBITDA	-23M -59M

Soovitused
By TipRanks
Soovitused	Osta
12 kuu keskmine prognoos	+81.36% upside

Dividendid
By Dow Jones
Järgmine tulemuste avaldamine	11. mai 2026

Turustatistika
By TradingEconomics
Turukapital	-36M 506M
Eelmine avamishind	20.15
Eelmine sulgemishind	23.69

Tehniline skoor

By Trading Central

Kindlus

Strong Bearish Evidence

0.4217 / 0.4691 Toetus ja vastupanu

Lyell Immunopharma Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

8. apr 2026, 20:44 UTC

Tulu

Costco Reports 11% Growth in March Sales

8. apr 2026, 23:51 UTC

Market Talk

Global Equities Roundup: Market Talk

8. apr 2026, 23:51 UTC

Market Talk

Nikkei May Rise on Hopes for Talks to End Iran War -- Market Talk

8. apr 2026, 23:36 UTC

Market Talk

Uudisväärsed sündmused

Gold Edges Lower on Likely Technical Correction -- Market Talk

8. apr 2026, 22:56 UTC

Market Talk

Ramelius Resources May Downgrade Cost Guidance This Month -- Market Talk

8. apr 2026, 22:45 UTC

Market Talk

Constellation Brands Points to Continuing Challenges Among Hispanic Consumers -- Market Talk

8. apr 2026, 22:17 UTC

Market Talk

Applied Digital Says Its Holding Out for Quality Customers -- Market Talk

8. apr 2026, 21:52 UTC

Uudisväärsed sündmused

A Closer Look at Iran's 10 Demands -- and Which the U.S. Might Accept -- Update

8. apr 2026, 21:24 UTC

Tulu

FedEx Freight Aims for 12% Profit Growth. How That Compares to the Leader. -- Barrons.com

8. apr 2026, 21:01 UTC

Uudisväärsed sündmused

Oil Prices Tumble Despite Conflicting Reports About the Strait of Hormuz -- Barrons.com

8. apr 2026, 20:50 UTC

Market Talk

Energy & Utilities Roundup: Market Talk

8. apr 2026, 20:43 UTC

Omandamised, ülevõtmised, äriostud

Oracle Is Expressing No Opinion and Is Neutral as to Whether Stockholders Should Tender Their Shrs in Response to TRC's Offer >ORCL

8. apr 2026, 20:43 UTC

Omandamised, ülevõtmised, äriostud

Oracle Does Not Endorse TRC's Mini-Tender Offer or the Offer Documentation >ORCL

8. apr 2026, 20:43 UTC

Omandamised, ülevõtmised, äriostud

Oracle: Offer Represents Less Than 0.04% of Outstanding Common Stk >ORCL

8. apr 2026, 20:42 UTC

Omandamised, ülevõtmised, äriostud

Oracle: TRC Offer Is to Purchase Up to 1M Shrs of Common Stk at $140.50/Shr in Cash >ORCL

8. apr 2026, 20:42 UTC

Omandamised, ülevõtmised, äriostud

Oracle Received Notice of Unsolicited Mini-Tender Offer by TRC Dated March 24 >ORCL

8. apr 2026, 20:42 UTC

Omandamised, ülevõtmised, äriostud

Oracle Responds to TRC Cap Mini-Tender Offer

8. apr 2026, 20:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

8. apr 2026, 20:11 UTC

Omandamised, ülevõtmised, äriostud

Intel Corp.: Repurchased 49% Equity Interest in JV Related to Intel's Fab 34 in Ireland >INTC

8. apr 2026, 20:11 UTC

Omandamised, ülevõtmised, äriostud

Intel Corp.: $14.2B Repurchase Price Financed with Cash on Hand and a Bridge Loan of $6.5B >INTC

8. apr 2026, 20:11 UTC

Omandamised, ülevõtmised, äriostud

Intel Corp.: Repurchased JV Stake From Apollo-Managed Funds and Affiliates >INTC

8. apr 2026, 19:44 UTC

Tulu

These Companies Pay 5% Dividend Yields, and They're Hiking Them Too -- Barrons.com

8. apr 2026, 19:16 UTC

Market Talk

Hogs Follow Cutout Prices Lower -- Market Talk

8. apr 2026, 19:02 UTC

Market Talk

Global Energy Roundup: Market Talk

8. apr 2026, 19:02 UTC

Market Talk

Oil Futures Plunge as Cease-Fire Raises Hopes for Restored Supply -- Market Talk

8. apr 2026, 18:58 UTC

Market Talk

U.S. Natural Gas Futures Fall in Line With Slump in Oil -- Market Talk

8. apr 2026, 18:51 UTC

Market Talk

Global Equities Roundup: Market Talk

8. apr 2026, 18:51 UTC

Market Talk

Levi Strauss CEO Says Expanded Offerings, DTC Focus Are Working -- Market Talk

8. apr 2026, 18:14 UTC

Uudisväärsed sündmused

Fed Minutes Suggest a Lengthy Iran War Could Lead to Rate Hikes -- Barrons.com

8. apr 2026, 18:05 UTC

Uudisväärsed sündmused

Oil Prices Continue to Tumble After Cease-Fire Despite Slow Reopening of Strait of Hormuz -- Barrons.com

Võrdlus sarnastega

Hinnamuutus

Lyell Immunopharma Inc Prognoos

Hinnasiht

By TipRanks

81.36% tõus

12 kuu keskmine prognoos

Keskmine 39.5 USD 81.36%

Kõrge 45 USD

Madal 34 USD

Põhineb 2 Wall Streeti analüütiku instrumendi Lyell Immunopharma Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

2 ratings

2

Osta

0

Hoia

0

Müü

Põhineb 2 analüütiku instrumendi Lyell Immunopharma Inc aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

0.4217 / 0.4691Toetus ja vastupanu

Recent bearish events outweigh bullish events.

There is one bearish event.

There are no events.

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Muud aktsiad sektorist

MDT

Medtronic PLC

88.49

A

Agilent Technologies Inc

115.97

VEEV

Veeva Systems Inc

157.32

HQY

HealthEquity Inc

83.84

TLRY

Tilray Brands Inc

6.83

Live chat